Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 30, 2016 | $33.3B |
| FY2017, ended Dec 31, 2017 | $48.8B |
| FY2018, ended Dec 31, 2018 | $50.7B |
| FY2019, ended Dec 31, 2019 | $56.0B |
| FY2020, ended Dec 31, 2020 | $69.2B |
| FY2021, ended Dec 31, 2021 | $82.5B |
| FY2022, ended Dec 31, 2022 | $63.9B |
| FY2023, ended Dec 31, 2023 | $67.9B |
| FY2024, ended Dec 31, 2024 | $61.1B |
| FY2025, ended Dec 31, 2025 | $67.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $85.7B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 30, 2016 | $11.1B |
| FY2017, ended Dec 31, 2017 | $11.4B |
| FY2018, ended Dec 31, 2018 | $12.3B |
| FY2019, ended Dec 31, 2019 | $11.9B |
| FY2020, ended Dec 31, 2020 | $10.6B |
| FY2021, ended Dec 31, 2021 | $12.5B |
| FY2022, ended Dec 31, 2022 | $14.9B |
| FY2023, ended Dec 31, 2023 | $14.7B |
| FY2024, ended Dec 31, 2024 | $14.5B |
| FY2025, ended Dec 31, 2025 | $14.1B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $14.9B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 30, 2016 | $1.71B | $643M |
| FY2017, ended Dec 31, 2017 | $5.47B | $1.43B |
| FY2018, ended Dec 31, 2018 | $3.31B | $2.90B |
| FY2019, ended Dec 31, 2019 | $3.33B | $3.19B |
| FY2020, ended Dec 31, 2020 | $2.77B | $2.64B |
| FY2021, ended Dec 31, 2021 | $3.78B | $3.31B |
| FY2022, ended Dec 31, 2022 | $4.11B | $3.41B |
| FY2023, ended Dec 31, 2023 | $3.67B | $3.26B |
| FY2024, ended Dec 31, 2024 | $3.47B | $2.72B |
| FY2025, ended Dec 31, 2025 | $2.89B | $1.71B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $3.58B | $3.21B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 30, 2016 | $603M |
| FY2017, ended Dec 31, 2017 | $401M |
| FY2018, ended Dec 31, 2018 | $858M |
| FY2019, ended Dec 31, 2019 | $958M |
| FY2020, ended Dec 31, 2020 | $3.13B |
| FY2021, ended Dec 31, 2021 | $2.24B |
| FY2022, ended Dec 31, 2022 | $1.96B |
| FY2023, ended Dec 31, 2023 | $1.35B |
| FY2024, ended Dec 31, 2024 | $933M |
| FY2025, ended Dec 31, 2025 | $670M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.22B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 30, 2016 | $11.3B |
| FY2017, ended Dec 31, 2017 | $11.8B |
| FY2018, ended Dec 31, 2018 | $14.8B |
| FY2019, ended Dec 31, 2019 | $16.2B |
| FY2020, ended Dec 31, 2020 | $16.7B |
| FY2021, ended Dec 31, 2021 | $16.4B |
| FY2022, ended Dec 31, 2022 | $18.0B |
| FY2023, ended Dec 31, 2023 | $18.5B |
| FY2024, ended Dec 31, 2024 | $18.5B |
| FY2025, ended Dec 31, 2025 | $18.9B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $18.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 33.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 30, 2016 | 2.78B |
| FY2017, ended Dec 31, 2017 | 2.66B |
| FY2018, ended Dec 31, 2018 | 2.45B |
| FY2019, ended Dec 31, 2019 | 2.32B |
| FY2020, ended Dec 31, 2020 | 2.29B |
| FY2021, ended Dec 31, 2021 | 2.19B |
| FY2022, ended Dec 31, 2022 | 2.06B |
| FY2023, ended Dec 31, 2023 | 1.96B |
| FY2024, ended Dec 31, 2024 | 1.89B |
| FY2025, ended Dec 31, 2025 | 1.86B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 1.84B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 30, 2016 | $1.06B | $37.0M | — |
| FY2017, ended Dec 31, 2017 | $1.97B | $89.0M | — |
| FY2018, ended Dec 31, 2018 | $4.67B | $51.0M | — |
| FY2019, ended Dec 31, 2019 | $3.37B | $74.0M | — |
| FY2020, ended Dec 31, 2020 | $867M | $29.0M | — |
| FY2021, ended Dec 31, 2021 | $2.89B | $107M | — |
| FY2022, ended Dec 31, 2022 | $4.73B | $74.0M | $422M |
| FY2023, ended Dec 31, 2023 | $3.48B | $60.0M | — |
| FY2024, ended Dec 31, 2024 | $2.24B | $40.0M | — |
| FY2025, ended Dec 31, 2025 | $1.40B | $54.0M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.17B | $71.0M | — |
Valuation
At current price- Market Cap
- $96.4B
- P/E
- 26.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 6.4×
- Price / Book
- 6.7×
- EV / EBITDA
- 16.1×
Growth
Trailing 12 months- Revenue (TTM)
- $14.9B
- Revenue Growth YoY
- 5.8%
- Revenue CAGR 3Y
- −1.7%
- Revenue CAGR 5Y
- 5.9%
- EPS Growth YoY
- 23.9%
- Net Income Growth YoY
- 23.4%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 36.4%
- Net Margin
- 24.0%
- FCF Margin
- 21.5%
- Return on Equity
- 26.4%
Earnings
Trailing 12 months- Net Income
- $3.58B
- EPS (diluted)
- $1.92
- EBITDA
- $7.08B
- Operating Income
- $5.44B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $1.22B
- Total Debt
- $18.8B
- Net Debt
- $17.6B
- Total Assets
- $45.2B
- Total Liabilities
- $30.8B
- Shareholders' Equity
- $14.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $5.60B
- Capital Expenditure
- $2.39B
- Free Cash Flow
- $3.21B
Dividends and risk
Last 12 months- Dividend Yield
- 1.1%
- Dividend / Share
- $0.55
- Beta (5Y)
- 1.20
Every ratio is calculated from the company’s reported figures.